Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Abebe Gule Girma"'
Autor:
Abebe Gule Girma
In the current business environment, the financial performance of companies and its determinant factors are considered as a key issues. The purpose of this study was to examine the impact of firm-specific and macroeconomic factors on the financial pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bbc6148e5e18b0e304d02218cd2a0bd
https://doi.org/10.21203/rs.3.rs-2381160/v1
https://doi.org/10.21203/rs.3.rs-2381160/v1
Autor:
Eshetu Wendimu, Beniam Adera Gebru, Selamawit Mulat, Tadesse Birhanu, Bosenu Abera Tadesse, Qamar Kassim Yusuf, Nigus Shimelis Zeleke, Abebe Gule Girma, Amana Ogeto Luke, Ali Kazemi, Berhanu Senbeta Deriba, Addis Adera Gebru, Agumas Fentahun Ayalew, Hussen Zakir Abasimel, Dejene Hailu, Bulgantsetseg Munkhbat
Publikováno v:
Human Antibodies. 29:129-137
BACKGROUND: The Novel Coronavirus Disease 2019 (COVID-19) has proved to be one of the most burdensome respiratory disease outbreaks ever. Moreover, the public health emergency of the COVID-19 outbreak has been seen by the World Health Organization (W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29a6c2b91dc070cfe9d75dd629678b9c
https://doi.org/10.3233/hab-200422
https://doi.org/10.3233/hab-200422
Autor:
Eshetu Wendimu, Qamar Kassim Yusuf, Nigus Shimelis Zeleke, Amana Ogeto Luke, Agumas Fentahun Ayalew, Tadesse Birhanu, Addis Adera Gebru, Ali Kazemi, Abebe Gule Girma, Hussen Zakir Abasimel, Beniam Adera Gebru, Selamawit Mulat, Bulgantsetseg Munkhbat, Dejene Hailu, Bosenu Abera Tadesse, Berhanu Senbeta Deriba
Publikováno v:
Human Antibodies. 29:149-169
BACKGROUND: The novel Coronavirus Disease 2019 is the major public health burden in the world. The disease and death of the global community from corona virus disaes 19 rapidly increasing from time to time worldwide. However, there was a lack of well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a8d03069cd1cd9f87e26cfa81ec2eda
https://doi.org/10.3233/hab-200421
https://doi.org/10.3233/hab-200421
Autor:
Addis Adera Gebru, Eshetu Wendimu, Bosenu Abera Tadesse, Amana Ogeto Luke, Agumas Fentahun Ayalew, Bulgantsetseg Munkhbat, Qamar Kassim Yusuf, Beniam Adera Gebru, Dejene Hailu, Nigus Shimelis Zeleke, Tadesse Birhanu, Selamawit Mulat, Ali Kazemi, Hussen Zakir Abasimel, Berhanu Senbeta Deriba, Abebe Gule Girma
Publikováno v:
Human antibodies. 29(2)
BACKGROUND: The novel Coronavirus Diseases 2019 (COVID-19) is the major public health burden in the world. The morbidity and mortality of global community due to this disease is dramatically increasing from time to time. OBJECTIVE: This situational a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d293b8359f03812a3d611f9737d70635
https://pubmed.ncbi.nlm.nih.gov/32804122
https://pubmed.ncbi.nlm.nih.gov/32804122